LexDanaLexDanabeta
Inventor

Ish K. Khanna

Inventor
Vernon Hills, IL, US

Overview

76→
Patents
1990–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 76 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes6%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07KPeptides1%
PatentTitleYear
9,782,407'Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors'20179,765,030'Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors'20179,303,027'Kappa opioid receptor agonists'20169,040,558'Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors'20158,623,897'Methods and compositions for treatment of diabetes and dyslipidemia'20148,604,055'Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors'20138,008,328'Methods for the treatment of diabetes-associated dyslipdemia'20117,989,463'Biccyclic compounds as GATA modulators'20117,820,654'Pyrimidine compounds, process for their preparation and compositions containing them'20107,700,774'Heterocyclic compounds and their pharmaceutical compositions'20107,622,486'Pyridine compounds, process for their preparation and compositions containing them'20097,420,061'Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors'20087,220,770'Heterocyclo-substituted imidazoles for the treatment of inflammation'20077,153,959'Substituted pyrazoles as p38 kinase inhibitors'20067,119,098'Heteroarylakanoic acids as intergrin receptor antagonists'20067,119,203'Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors'20067,071,198'Substituted pyrazoles as p38 kinase inhibitors'20066,979,686'Substituted pyrazoles as p38 kinase inhibitors'20056,951,949'Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation'20056,949,578'Cycloalkyl alkanoic acids as integrin receptor antagonists'20056,933,304'Heteroarylalkanoic acids as integrin receptor antagonists'20056,921,767'Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives'20056,900,232'Cycloalkyl alkanoic acids as integrin receptor antagonists'20056,833,366'Dihydrostilbene alkanoic acid derivatives'20046,815,460'Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors'20046,720,315'Dihydrostilbene alkanoic acid derivatives'20046,716,991'Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation'20046,689,754'Heterocyclic glycyl -alanine derivatives'20046,617,324'Substituted pyrazoles as p38 kinase inhibitors'20036,613,789'Heterocyclo-substituted imidazoles for the treatment of inflammation'20036,586,603'Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation'20036,531,494'Gem-substituted v3 antagonists'20036,525,059'Substituted pyrazoles as p38 kinase inhibitors'20036,514,977'Substituted pyrazoles as p38 kinase inhibitors'20036,492,411'Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation'20026,436,967'Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors'20026,423,713'Substituted pyrazoles as p38 kinase inhibitors'20026,413,960'Substituted pyrazolyl benzenesulfonamides for the treatment of asthma'20026,156,781'Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation'20005,935,990'Substituted pyrrolyl compounds for the treatment of inflammation'19995,932,598'Prodrugs of benzenesulfonamide-containing COX-2 inhibitors'19995,861,403'Purinylalkyl benzamide derivatives'19995,852,210'Cinnamic acid derivatives'19985,760,068'Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation'19985,753,688'Substituted pyrazolyl benzenesulfonamides for the treatment of gastrointestinal conditions'19985,688,822'Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as inhibitors of 5-lipoxygenase'19975,652,363'Pyrido-1,4-oxazinylalkyl-benzamide derivatives'19975,639,882'2-substituted tertiary carbinol derivatives of 1,5-iminosugars'19975,637,707'2-substituted tertiary carbinol derivatives of 1, 5-iminosugars'19975,635,514'Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors'19975,616,601'1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation'19975,563,165'Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation'19965,550,243'B preparation of 2- and 3- azido derivates of 1,5-iminosugars'19965,530,132'2-substituted tertiary carbinol derivatives of 1,5-iminosugars'19965,523,406'2-substituted tertiary carbinol derivatives of 1,5-iminosugars'19965,508,426'Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation'19965,504,215'Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation'19965,502,193'2-substituted tertiary carbinol derivatives of 1,5-iminosugars'19965,466,823'Substituted pyrazolyl benzenesulfonamides'19955,436,341'Intermediates for 2,3-diamino-1,5-iminosugars'19955,391,746'Intermediates for 3-amino and 3-azido derivatives of 1,5-iminosugars'19955,359,073'Substituted-phenyl (N,N\'-cycloalkyl/alkyl carboxamide)-1H/3H-imidazo[4,5-b]pyridine compounds as PAF antagonists'19945,350,854'2-substituted tertiary carbinol derivative of 1,5-iminosugars'19945,334,717'Intermediates for 2-amino and azido derivatives of 1,5-iminosugars'19945,281,724'Process for the preparation of 6-(n-butylamino)-6-deoxy-1,2-O-(imeihylethylidine)-a-L-Sorbofuranose and derivatives thereof'19945,270,468'2- and 3- amino azido derivatives of 1,5-iminosugars'19935,262,426'N,N\'-cycloalkyl/alkyl carboxamide 4H-imidazo-[4,5-b]pyridine compounds as PAF antagonists'19935,258,518'2-substituted tertiary carbinol derivatives of deoxynojirimycin'19935,227,384'5-substituted [4,5-c] imidazopyridines and pharmaceutical use thereof'19935,216,168'2- and 3- amino and azido derivatives of 1,5-iminosugars'19935,208,242'5-substituted-4-phenyl-5H-imidazo[4,5-c]pyridine derivatives'19935,206,251'2- and 3- amino and azido derivatives of 1,5-iminosugars'19935,151,519'Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-D-glucitol and derivatives thereof'19925,019,581'5-substituted (4,5-c) imidazopyridine compounds which have useful platelet activating factor antagonistic activity'19914,990,518'Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines'19914,914,108'5-substituted(4,5-c)imidazopyridine compounds which have useful platelet activating factor antagonistic activity'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1990–2004Patents assigned to SEARLE & CO (47)· patent assignee history
1990–1993Based in Skokie, IL, US· patent location history
1991–2007Based in Vernon Hills, IL, US· patent location history
2002–2008Patents assigned to PHARMACIA CORP (16)· patent assignee history
2002–2008Based in Libertyville, IL, US· patent location history
2009–2017Based in Alpharetta, GA, US· patent location history
2010–2016Patents assigned to REDDYS LAB LTD DR (6)· patent assignee history
2013–2016Patents assigned to KHANNA ISH KUMAR (3)· patent assignee history
2013–2015Patents assigned to PILLARISETTI SIVARAM (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SEARLE & CO471990–2004
PHARMACIA CORP162002–2008
REDDYS LAB LTD DR62010–2016
KHANNA ISH KUMARself32013–2016
PILLARISETTI SIVARAM32013–2015
Locations
LocationPatentsSpan
Vernon Hills, Illinois, US431991–2007
Libertyville, Illinois, US192002–2008
Alpharetta, Georgia, US112009–2017
Skokie, Illinois, US31990–1993